Who is sponsoring CoMet?

CoMet is sponsored by Galderma R&D.

What condition does CoMet study?

CoMet studies Actinic Keratoses.

What drugs are being tested in CoMet?

Interventions: Metvix and natural daylight PDT, Metvix and conventional PDT.

Last reviewed 2021-02-16 · How we verify

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses. (CoMet)

NCT01475071 Phase 3 COMPLETED Results posted

The main objective of this study is to compare efficacy and safety of Metvix® natural daylight photodynamic therapy with those of Metvix® conventional photodynamic therapy with Aktilite™ lamp in subjects with mild actinic keratoses (intra-individual comparison).

Details

Lead sponsor	Galderma R&D
Phase	Phase 3
Status	COMPLETED
Enrolment	100
Start date	2012-03
Completion	2013-03

Conditions

Actinic Keratoses

Interventions

Metvix and natural daylight PDT
Metvix and conventional PDT

Primary outcomes

Lesion Response — Week12
Percent of lesions treated at Baseline, in complete response at Week 12
Pain Score — Baseline (during procedure), assessed after procedure
Subject self assessment of pain on a scale from 0 (no pain ) to 10 (extreme pain)

Countries

Australia